Supreme Court Rejects Teva's Bid to Protect Copaxone Patent

A U.S. Supreme Court justice refused to stay a ruling that would open Teva Pharmaceutical Industries' Copaxone multiple-sclerosis drug to generic competition in May 2014.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news